User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 18 results.
    • Journal article
    Predictors of Benefit in Colorectal Cancer Treated With Cetuximab: Are We Getting "Lost in TranslationAL"? Reply
    Jacobs, Bart[UCL] Piessevaux, Hubert[UCL] De Roock, Wendy[UCL] Biesmans, Bart[UCL] De Schutter, Jef[UCL] Claes, Bart[UCL] Tejpar, Sabine[UCL] (2010) Journal of Clinical Oncology — Vol. 28, no. 11, p. E175-E176 (2010)
    • Speech
    Levels of amphiregulin and epiregulin expression correlate with overall survival in colorectal cancer treated with cetuximab
    De Roock, Wendy[UCL] Piessevaux, Hubert[UCL] Biesmans, Bart[UCL] De Schutter, Jef[UCL] Van Cutsem, Emmanuel[UCL] Tejpar, Sabine[UCL] (2007) Annual Meeting of the EORTC-NCI-ASCO on Molecular Markers in Cancer — Brussels (Belgium)
    • Speech
    High Amphiregulin and Epiregulin expression in K-ras wild type colorectal primaries predicts response and survival benefit after treatment with cetuximab and irinotecan for metastatic disease
    Tejpar, Sabine[UCL] Piessevaux, Hubert[UCL] Humblet, Yves[UCL] De Roock, Wendy[UCL] Biesemans, Bart[UCL] De Schutter, Jef[UCL] Peeters, Marc Celik, Ilhan Van Cutsem, Eric[UCL] (2007) —
    • Journal article
    Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway.
    Dercle, Laurent Lu, Lin Schwartz, Lawrence H Qian, Min Tejpar, Sabine Eggleton, Peter Zhao, Binsheng Piessevaux, Hubert[UCL] (2020) Journal of the National Cancer Institute — Vol. 112, no.9, p. 902-912 (2020)
    • Journal article
    Clinical and pharmacogenetic determinants of 5-fluorouracyl/leucovorin/irinotecan toxicity: Results of the PETACC-3 trial
    Tejpar, Sabine Yan, Pu Piessevaux, Hubert[UCL] Dietrich, Daniel Brauchli, Peter Klingbiel, Dirk Fiocca, Roberto Delorenzi, Mauro Bosman, Fred Roth, Arnaud D. (2018) European Journal of Cancer — Vol. 99, p. 66-77 (2018)
    • Journal article
    FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: An international consortium study
    Geva, Ravit Vecchione, Loredana Kalogeras, Konstantinos T. Jensen, Benny Vittrup Lenz, Heinz-Josef Yoshino, Takayuki Paez, David Montagut, Clara Souglakos, John Cappuzzo, Federico Cervantes, Andrés Frattini, Milo Fountzilas, George Johansen, Julia S. Høgdall, Estrid Vilma Zhang, Wu Yang, Dongyun Yamazaki, Kentaro Nishina, Tomohiro Papamichael, Demetris Vincenzi, Bruno Macarulla, Teresa Loupakis, Fotios De Schutter, Jef Spindler, Karen Lise Garm Pfeiffer, Per Ciardiello, Fortunato Piessevaux, Hubert[UCL] Tejpar, Sabine (2015) Gut — Vol. 64, no. 6, p. 921-928 (2015)
    • Journal article
    A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy
    Saridaki, Zenia Weidhaas, Joanne B. Lenz, Heinz-Josef Laurent-Puig, Pierre Jacobs, Bart De Schutter, Jef De Roock, Wendy Salzman, David W. Zhang, Wu Yang, Dongyun Pilati, Camilla Bouché, Olivier Piessevaux, Hubert[UCL] Tejpar, Sabine (2014) Clinical Cancer Research — Vol. 20, no. 17, p. 4499-4510 (2014)
    • Journal article
    Reply to C. Cremolini et al
    Jacobs, Bart De Roock, Wendy Piessevaux, Hubert[UCL] Biesmans, Bart De Schutter, Jef Claes, Bart Tejpar, Sabine (2010) Journal of Clinical Oncology — Vol. 28, no. 11, p. e175-e176 (2010)
    • Journal article
    Use of early tumor shrinkage to predict long-term outcome in metastatic colorectal cancer treated with cetuximab.
    Piessevaux, Hubert[UCL] Buyse, Marc Schlichting, Michael Van Cutsem, Eric Bokemeyer, Carsten Heeger, Steffen Tejpar, Sabine (2013) Journal of Clinical Oncology — Vol. 31, no.30, p. 3764-3775 (2013)
    • Journal article
    Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer.
    Geva, Ravit Vecchione, Loredana Tejpar, Sabine Piessevaux, Hubert[UCL] Van Cutsem, Eric Prenen, Hans (2013) OncoTargets and Therapy — Vol. 6, p. 53-58 (2013)
    • Journal article
    Personalized medicine in metastatic colorectal cancer treated with anti-epidermal growth factor receptor agents: A future opportunity?
    Tejpar, Sabine Piessevaux, Hubert[UCL] (2014) Asia Pacific Journal of Clinical Oncology — Vol. 10, no. SUPPL.1, p. 2-10 (2014)
    • Journal article
    Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab
    Jacobs, Bart De Roock, Wendy Piessevaux, Hubert[UCL] Van Oirbeek, Robin Biesmans, Bart De Schutter, Jef Fieuws, Steffen Vandesompele, Jo Peeters, Marc Van Laethem, Jean-Luc Humblet, Yves[UCL] Pénault-Llorca, Frédérique De Hertogh, Gert Laurent-Puig, Pierre Van Cutsem, Eric Tejpar, Sabine (2009) Journal of Clinical Oncology — Vol. 27, no. 30, p. 5068-5074 (2009)
    • Journal article
    KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab
    De Roock, Wendy Piessevaux, Hubert[UCL] De Schutter, Jef Janssens, Marc De Hertogh, Gert Personeni, Nicola Biesmans, Bart Van Laethem, Jean-Luc Peeters, Marc Humblet, Yves[UCL] Van Cutsem, Eric Tejpar, Sabine (2008) Annals of Oncology — Vol. 19, no. 3, p. 508-515 (2008)
    • Journal article
    Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study
    Tejpar, Sabine Piessevaux, Hubert[UCL] Claes, Kathleen Piront, Patricia Hoenderop, Joost G. J. Verslype, Chris Van Cutsem, Eric[UCL] (2007) The Lancet Oncology — Vol. 8, no. 5, p. 387-394 (2007)
    • Journal article
    Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
    De Roock, Wendy Piessevaux, Hubert[UCL] Jonker, Derek J. Di Nicolantonio, Federica Sartore-Bianchi, Andrea Tu, Dongsheng Siena, Salvatore Lamba, Simona Arena, Sabrina Frattini, Milo Van Cutsem, Eric[UCL] O'Callaghan, Chris J. Khambata-Ford, Shirin Zalcberg, John R. Simes, John Karapetis, Christos S. Bardelli, Alberto Tejpar, Sabine[UCL] (2010) JAMA : the journal of the American Medical Association — Vol. 304, no. 16, p. 1812-20 (2010)
    • Journal article
    Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab : A fluorescent in situ hybridization study
    Personeni, Nicola Fieuws, Steffen Piessevaux, Hubert[UCL] De Hertogh, Gert De Schutter, Jef Biesmans, Bart De Roock, Wendy Capoen, An Debiec-Rychter, Maria Van Laethem, Jean-Luc Peeters, Marc Humblet, Yves[UCL] Van Cutsem, Eric Tejpar, Sabine (2008) Clinical Cancer Research — Vol. 14, no. 18, p. 5869-5876 (2008)
    • Journal article
    Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
    De Roock, Wendy[UCL] Piessevaux, Hubert[UCL] Claes, Bart[UCL] De Schutter, Jef[UCL] Biesmans, Bart[UCL] Van Cutsem, Eric[UCL] Lambrechts, Diether[UCL] Tejpar, Sabine[UCL] (2010) The Lancet Oncology — Vol. 11, no. 8, p. 753-762 (2010)
    • Journal article
    Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial).
    Piessevaux, Hubert[UCL] Buyse, M. De Roock, Wendy[UCL] Prenen, H Schlichting, M Van Cutsem, Emmanuel[UCL] Tejpar, Sabine[UCL] (2009) Annals of oncology : official journal of the European Society for Medical Oncology / ESMO — Vol. 20, no. 8, p. 1375-82 (2009)